Javascript must be enabled to continue!
Liver Metastases Pattern in Rectal Cancer: A Real-World Analysis in the SEER Database
View through CrossRef
Background: The liver is a common metastatic site of colorectal cancer. Rectal cancer patients with organ metastases are more liable to show poor prognosis. The hazard and forecast elements of liver metastases are need to be estimated in rectal cancer patients. Methods: The data of newly diagnosed patients of rectal cancer with liver metastases are evaluated according to Surveillance, Epidemiology, and End Results (SEER) program between 2010 and 2016. The Overall Survival (OS) for dierent subgroups are appraised by Kaplan-Meier analysis and log-rank tests. Univariate and multivariable logistic analysis and Cox regression are performed to evaluate predictors and elements of the presence of liver metastases in new diagnosis, respectively. Results: There are a total of 6,662 (11.1%) rectal cancer patients paired with liver metastases. Factors including age (below), gender (female), marital status (unmarried), race (black), advanced T or N classification, presence of bone or lung metastases, and the absence of surgical treatments are importantly related to the occurrence of liver metastases. The median survival for liver metastases rectal cancer patients was 16.0 months. Indicators referring to elder age, black race, unmarried status, presence of bone, brain or lung metastases, and the absence of surgical treatments all predicted worse survival. Conclusion: The data of our research provide corresponding risks and prognostic elements for liver metastases rectal cancer patients, which offer a way to predict the occurrence of rectal cancer and guide prophylactic treatment in clinical settings.
Title: Liver Metastases Pattern in Rectal Cancer: A Real-World Analysis in the SEER Database
Description:
Background: The liver is a common metastatic site of colorectal cancer.
Rectal cancer patients with organ metastases are more liable to show poor prognosis.
The hazard and forecast elements of liver metastases are need to be estimated in rectal cancer patients.
Methods: The data of newly diagnosed patients of rectal cancer with liver metastases are evaluated according to Surveillance, Epidemiology, and End Results (SEER) program between 2010 and 2016.
The Overall Survival (OS) for dierent subgroups are appraised by Kaplan-Meier analysis and log-rank tests.
Univariate and multivariable logistic analysis and Cox regression are performed to evaluate predictors and elements of the presence of liver metastases in new diagnosis, respectively.
Results: There are a total of 6,662 (11.
1%) rectal cancer patients paired with liver metastases.
Factors including age (below), gender (female), marital status (unmarried), race (black), advanced T or N classification, presence of bone or lung metastases, and the absence of surgical treatments are importantly related to the occurrence of liver metastases.
The median survival for liver metastases rectal cancer patients was 16.
0 months.
Indicators referring to elder age, black race, unmarried status, presence of bone, brain or lung metastases, and the absence of surgical treatments all predicted worse survival.
Conclusion: The data of our research provide corresponding risks and prognostic elements for liver metastases rectal cancer patients, which offer a way to predict the occurrence of rectal cancer and guide prophylactic treatment in clinical settings.
Related Results
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
Woningcorporaties en Vastgoedontwikkeling
Woningcorporaties en Vastgoedontwikkeling
This summary highlights the findings of the PhD-thesis ‘Woningcorporaties en Vastgoedontwikkeling: Fit for Use’ (‘Housing associations and Real Estate Development: Fit for Use?’). ...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study
Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study
Abstract
Background
Gallbladder cancer is a rare but highly malignant cancer, which often progresses to a metastatic stag...
Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study
Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study
Abstract
Background: Gallbladder cancer is a rare but highly malignant cancer, which often progresses to a metastatic stage when diagnosed because of its asymptomatic manif...

